During the past decade, Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 6 clinical trials were completed, i.e. on average, 31.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"" #1 collaborator was "CML Advocates Network" with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"" are "Chronic Lymphocytic Leukemia" (5 trials), "Chronic Myeloid Leukemia" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"" in a lesser frequency.

Most popular intervention types in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"" are "Drug" (22 trials), "Other" (4 trials), "Behavioral" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (5 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Ibrutinib" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"" are 32 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte"". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte", 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".